CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]

Context Therapeutics has reported encouraging interim Phase 1 data for [...]

Verdiva Bio has reported new preclinical data for two obesity [...]

CuraCell TX has reported new findings supporting its personalised tumour-infiltrating [...]

Evogene has reported positive Phase 1 data for microbiome-based therapy [...]

Quotient Sciences has begun a Phase 1 clinical study evaluating [...]

Mestag Therapeutics has dosed the first patient in its Phase [...]

Kainova Therapeutics has dosed the first patient in Europe in [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]

Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]